Rodriguez-Otero, P., Delimpasi, S., Oriol, A., Dimopoulos, M. A., Leleu, X. P., Manier, S., Martínez-Chamorro, C., Chakraborty, R., Rubinstein, S., Sureda, A., Gonzalez, M. S., Michot, J., Breazna, A., Drew, J., Boyapati, A., Masinde, S., Kroog, G. S., Sarkaria, S. M., Martínez-López, J. (2025). Linvoseltamab (LINVO) + bortezomib (BTZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): First results from the LINKER-MM2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7510